Estradiol -triene-3 recalled over manufacturing violations
- Recall date
- April 13, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Spectrum Laboratory Products, Inc. recalls Estradiol (17-B-Estradiol; Estra-1,3,5(10)-triene-3, 17B-diol; Oestradiol) Plant Base, Micronized, U.S.P active pharmac…
- Recall number
- D-0881-2017
- FDA classification
- Class II
- Brand / firm
- Spectrum Laboratory Products, Inc.
- Sold / distributed
- Nationwide in the USA
Why it was recalled
CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer for deviations from current Good Manufacturing Practices that were found during a recent FDA inspection.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Estradiol (17-B-Estradiol; Estra-1,3,5(10)-triene-3, 17B-diol; Oestradiol) Plant Base, Micronized, U.S.P active pharmaceutical ingredient, packaged in 1g, 5g, 25g, 6 x 25g, and 100g containers, Rx only, Spectrum Chemical Mfg. Corp, Gardena, CA 90248, New Brunswick, NJ 08901, Product code E1435.
Get recall alerts
Free email alert whenever Spectrum Laboratory Products, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Spectrum Laboratory Products, Inc.